Truist Securities Reiterates Buy on WAVE Life Sciences, Maintains $17 Price Target
Portfolio Pulse from richadhand@benzinga.com
Truist Securities analyst Joon Lee has reiterated a Buy rating on WAVE Life Sciences (NASDAQ:WVE) and maintained a $17 price target.
June 23, 2023 | 4:35 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Truist Securities analyst Joon Lee reiterates a Buy rating on WAVE Life Sciences (NASDAQ:WVE) and maintains a $17 price target.
The Buy rating and maintained price target by Truist Securities analyst Joon Lee indicates a positive outlook for WAVE Life Sciences. This news is likely to have a positive impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100